Global Veterinary Clostridium Vaccine Market 2017-2021

  • ID: 4335663
  • Report
  • Region: Global
  • 76 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Advaxis
  • ARKO Labs
  • Ceva
  • Epitopix
  • NEXVET
  • Vetoquinol
  • MORE
About Veterinary Clostridium Vaccine

Clostridium bacteria are widely found in soil and the guts of various animals. These microbes are anaerobic in nature and produce a wide range of toxins leading to various diseases in animals. Some of these diseases are zoonotic in nature. Vaccines play a major role in protecting the animals against all the Clostridia diseases. Various types of vaccines are available, either in a single form or in combinations, which consist of bacterins, toxoids, or mixtures of bacterins and toxoids.

The analysts forecast the global veterinary clostridium vaccine market to grow at a CAGR of 4.96% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global veterinary clostridium vaccine market for 2017-2021. To calculate the market size, the report considers sales of Clostridium vaccines.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Veterinary Clostridium Vaccine Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Elanco
  • Merck
  • Merial (now part of Boehringer Ingelheim)
  • Zoetis
Other prominent vendors
  • Advaxis
  • AMPLIPHI
  • Aratana Therapeutics
  • ARKO Labs
  • Bayer
  • CanFel Therapeutics
  • Ceva
  • Colorado Serum Company
  • Epitopix
  • Genus
  • Hygieia Biological Laboratories
  • NEXVET
  • Nuovo Biologics
  • Valneva SE
  • Vetoquinol
  • Virbac
Market drivers
  • Advances in technology
  • For a full, detailed list, view the full report
Market challenges
  • Manufacturing and storage issues
  • For a full, detailed list, view the full report
Market trends
  • Inorganic growth strategies
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Advaxis
  • ARKO Labs
  • Ceva
  • Epitopix
  • NEXVET
  • Vetoquinol
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: An overview of Clostridial Disease

PART 06: Market landscape
  • Market overview
  • Five forces analysis
PART 07: Market segmentation by species type
  • Swine
  • Bovine
  • Poultry
  • Others
PART 08: Geographical segmentation
  • Veterinary Clostridium vaccine market in Americas
  • Veterinary Clostridium vaccine market in EMEA
  • Veterinary Clostridium vaccine market in APAC
PART 09: Decision framework

PART 10: Drivers and challenges
  • Market drivers
  • Market challenges
PART 11: Market trends
  • Inorganic growth strategies
  • Combination vaccines
  • Industry-academia collaborations
PART 12: Vendor landscape
  • Competitive scenario
  • Competitive landscape analysis
PART 13: Key vendor analysis
  • Elanco
  • Merck
  • Merial (now part of Boehringer Ingelheim)
  • Zoetis
  • Other prominent vendors
PART 14: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Various clostridial diseases in animals
Exhibit 02: Global veterinary Clostridium vaccine market snapshot
Exhibit 03: Global veterinary Clostridium vaccine market 2016-2021 ($ millions)
Exhibit 04: Opportunity analysis in global veterinary Clostridium vaccine market
Exhibit 05: Five forces analysis
Exhibit 06: Market segmentation by type of species 2016
Exhibit 07: Global Clostridium swine vaccine market 2016-2021 ($ millions)
Exhibit 08: Species of Clostridium microbes affecting bovine animals
Exhibit 09: Global Clostridium bovine vaccine market 2016-2021 ($ millions)
Exhibit 10: Various commonly reported clostridial diseases in bovine animals
Exhibit 11: Global Clostridium poultry vaccine market 2016-2021 ($ millions)
Exhibit 12: Examples of few major animals from the segment
Exhibit 13: Global veterinary Clostridium vaccine market by other species 2016-2021 ($ millions)
Exhibit 14: Segmentation of global veterinary Clostridium vaccine market by geography 2016 and 2021 (%)
Exhibit 15: Global veterinary Clostridium vaccine market by geography 2016-2021 ($ millions)
Exhibit 16: Market scenario in Americas
Exhibit 17: Veterinary Clostridium vaccine market in Americas 2016-2021 ($ millions)
Exhibit 18: Market scenario in EMEA
Exhibit 19: Veterinary Clostridium vaccine market in EMEA 2016-2021 ($ millions)
Exhibit 20: Market scenario in APAC
Exhibit 21: Veterinary Clostridium vaccine market in APAC 2016-2021 ($ millions)
Exhibit 22: Major factors for CVB product approval
Exhibit 23: Recent strategic alliances in animal healthcare
Exhibit 24: USDA approved combination vaccines
Exhibit 25: Competitive structure analysis of global veterinary Clostridium vaccine market 2016
Exhibit 26: Competitive factors of global veterinary Clostridium vaccine market
Exhibit 27: Market penetration of various veterinary Clostridium vaccine manufacturers worldwide 2016
Exhibit 28: Strategic success factors of companies in global veterinary Clostridium vaccine market
Exhibit 29: Elanco: Key highlights
Exhibit 30: Elanco: Strength assessment
Exhibit 31: Elanco: Strategy assessment
Exhibit 32: Elanco: Opportunity assessment
Exhibit 33: Merck: Key highlights
Exhibit 34: Merck: Strength assessment
Exhibit 35: Merck: Strategy assessment
Exhibit 36: Merck: Opportunity assessment
Exhibit 37: Merial: Key highlights
Exhibit 38: Merial: Strength assessment
Exhibit 39: Merial: Strategy assessment
Exhibit 40: Merial: Opportunity assessment
Exhibit 41: Zoetis: Key highlights
Exhibit 42: Zoetis: Strength assessment
Exhibit 43: Zoetis: Strategy assessment
Exhibit 44: Zoetis: Opportunity assessment
Exhibit 45: Other prominent vendors
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Advaxis
  • ARKO Labs
  • Ceva
  • Epitopix
  • NEXVET
  • Vetoquinol
  • MORE
New Report Released: - Global Veterinary Clostridium Vaccine Market 2017-2021

The author of the report recognizes the following companies as the key players in the global veterinary clostridium vaccine market: Elanco, Merck, Merial (now part of Boehringer Ingelheim), and Zoetis.

Other Prominent Vendors in the market are: Advaxis, AMPLIPHI, Aratana Therapeutics, ARKO Labs, Bayer, CanFel Therapeutics, Ceva, Colorado Serum Company, Epitopix, Genus, Hygieia Biological Laboratories, NEXVET, Nuovo Biologics, Valneva SE, Vetoquinol, and Virbac.

Commenting on the report, an analyst from the research team said: “One trend in the market is inorganic growth strategies. The veterinary Clostridium vaccine market has been witnessing an increasing trend in strategic alliances and acquisitions among vendors. The vendors are planning for inorganic growth strategies such as acquisitions and partnerships to boost the research and to improve its penetration in emerging markets.”

According to the report, one driver in the market is advances in technology. The advances in technology have improved the overall pharmacokinetics and dynamics of vaccines along with cost-effective processes. The use of cell line culture in manufacturing viral vaccinations has been increased, which improved the quality of vaccinations. For instance, Valneva SE developed EB66 cell line, which can be used for high-efficiency vaccine production. This cell line is derived from stem cells of duck embryo. This can be used for large-scale manufacturing of veterinary vaccines.

Further, the report states that one challenge in the market is manufacturing and storage issues. A vaccine involves a complex network of processes ranging from manufacturing to delivery. The cost-intensive manufacturing issues associated with vaccines get quadrupled with strict regulatory laws. The protocol set by the FAO for manufacturing animal vaccines has rigorous processes like master seed and master stock analysis. These processes are crucial to producing quality vaccines, as they involve analysis of microbes, which are used in vaccine manufacturing followed by sterilization process and storage process.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Elanco
  • Merck
  • Merial (now part of Boehringer Ingelheim)
  • Zoetis
  • Advaxis
  • AMPLIPHI
  • Aratana Therapeutics
  • ARKO Labs
  • Bayer
  • CanFel Therapeutics
  • Ceva
  • Colorado Serum Company
  • Epitopix
  • Genus
  • Hygieia Biological Laboratories
  • NEXVET
  • Nuovo Biologics
  • Valneva SE
  • Vetoquinol
  • Virbac
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll